Australian researchers close in on malaria vaccine

July 2, 2013

Australian researchers said Tuesday they were closing in on a potential vaccine against malaria, with a study showing their treatment had protected mice against several strains of the disease.

Michael Good, from Queensland's Griffith University, said the vaccine led to naturally existing white blood cells, or T-cells, attacking the potentially deadly malaria parasite which lives in .

"A single vaccination induced profound immunity to different malaria parasite species," the study, published Tuesday in the Journal of Clinical Investigation, states.

Good said the team's research was focused on inducing the white blood cells to attack the parasite, whatever the .

"The T-cells (), when they're induced to kill malaria, can recognise proteins throughout the parasite, even internal proteins in the parasite," he told the ABC.

"So that's where we think the novel aspect is: we've been able to induce a form of which can recognise molecules in the parasite which are present in every single strain."

Good said he believed it was the first time that a vaccine had been shown to protect against more that two strains of malaria in mice.

The vaccine was expected to be cheap and easy to manufacture, he added, meaning that—if applicable to humans—it could have a significant impact in poor countries where malaria kills thousands each year.

"But we don't want to get ahead of ourselves; we want to demonstrate, first and foremost, that the vaccine is effective in humans," Good told the broadcaster.

In 2010 an estimated 219 million people were infected with the disease and some 660,000 died, most of them African children aged under five, the UN's World Health Organisation said in December.

A study published in the Lancet in February 2012 said the global death toll was more likely to be around 1.2 million a year.

Explore further: Cross-species malaria immunity induced by chemically attenuated parasites

More information: Cross-species malaria immunity induced by chemically attenuated parasites, J Clin Invest. doi:10.1172/JCI66634

Related Stories

Cross-species malaria immunity induced by chemically attenuated parasites

July 1, 2013
Malaria, a mosquito-born infectious disease, kills over 600,000 people every year. Research has focused on the development of a vaccine to prevent the disease; however, many malaria vaccines targeting parasite antigens have ...

Malaria's severity reset by mosquito

May 30, 2013
(Medical Xpress)—For the first time, researchers have proven that the way in which malaria is transmitted to the host affects how severe the resulting infection will be.

Improving human immunity to malaria

August 1, 2012
The deadliest form of malaria is caused the protozoan Plasmodium falciparum. During its life-cycle in human blood, the parasite P. falciparum expresses unique proteins on the surface on infected blood cells.

Lifting malaria's deadly veil: mystery solved in quest for vaccine

August 6, 2012
(Medical Xpress) -- Researchers at the Burnet Institute have made a major breakthrough in the quest for a vaccine against malaria, which causes up to one million deaths each year.

Researchers reveal malaria's deadly grip

June 5, 2013
Researchers at the University of Copenhagen, in collaboration with Seattle Biomedical Research Institute, the University of Oxford, NIMR Tanzania and Retrogenix LTD, have identified how malaria parasites growing inside red ...

New Japan malaria vaccine cuts infections 'by 72%'

May 31, 2013
A team of Japanese researchers say they have developed a vaccine that cuts the risk of malaria developing in humans by more than two-thirds.

Recommended for you

Forces from fluid in the developing lung play an essential role in organ development

January 23, 2018
It is a marvel of nature: during gestation, multiple tissue types cooperate in building the elegantly functional structures of organs, from the brain's folds to the heart's multiple chambers. A recent study by Princeton researchers ...

More surprises about blood development—and a possible lead for making lymphocytes

January 22, 2018
Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we are born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists ...

How metal scaffolds enhance the bone healing process

January 22, 2018
A new study shows how mechanically optimized constructs known as titanium-mesh scaffolds can optimize bone regeneration. The induction of bone regeneration is of importance when treating large bone defects. As demonstrated ...

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.